DownloadGlobal Health Campus,
Chemin du Pommier 40,
1218 Le Grand-Saconnex, Geneva, Switzerland
Annex L. Declaration of supply restrictions to countries DLM ITB-Iplus/GDF-MED/2024/1
Annex K. Form for Requests for Clarifications or Complaints after ITB awarding DLM ITB-Iplus/GDF-MED/2024/1
Annex J. GDF packaging artwork development guidelines DLM ITB-Iplus/GDF-MED/2024/1
Annex I. GMSD address list DLM ITB-Iplus/GDF-MED/2024/1
Annex H. Indicative non-binding estimated quantities DLM ITB-Iplus/GDF-MED/2024/1
Annex G. GDF access to supplier information for WHO PQP and ERP assessed TB medicines DLM ITB-Iplus/GDF-MED/2024/1
Annex F. CDP technical tender submission – instructions for use DLM ITB-Iplus/GDF-MED/2024/1
Annex E. i+solutions Code of Conduct for suppliers DLM ITB-Iplus/GDF-MED/2024/1
Annex D. i+solutions model Long-Term Agreement (LTA) DLM ITB-Iplus/GDF-MED/2024/1
Annex C. List of priority countries for TB medicines registration DLM ITB-Iplus/GDF-MED/2024/1